Short-Acting Insulins

Short-acting insulins are a class of antidiabetic agents, primarily consisting of regular human insulin, designed to mimic physiologic mealtime insulin release Typically demonstrating an onset of action within 30 to 60 minutes and a duration of about five to eight hours, this class is primarily indicated for glycemic control in type 1 and type 2 diabetes mellitus

Short-acting insulins are a class of antidiabetic agents, primarily consisting of regular human insulin, designed to mimic physiologic mealtime insulin release Typically demonstrating an onset of action within 30 to 60 minutes and a duration of about five to eight hours, this class is primarily indicated for glycemic control in type 1 and type 2 diabetes mellitus Additionally, short-acting regular insulin serves as a mainstay of intravenous therapy in acute metabolic emergencies such as diabetic...

They work by binding to cellular insulin receptors, stimulating peripheral glucose uptake into skeletal muscle and adipose tissue while suppressing hepatic glucose production Additionally, short-acting regular insulin serves as a mainstay of intravenous therapy in acute metabolic emergencies such as diabetic ketoacidosis and hyperosmolar hyperglycemic states

They work by binding to cellular insulin receptors, stimulating peripheral glucose uptake into skeletal muscle and adipose tissue while suppressing hepatic glucose production